Benzinga | Jan 7, 2021 06:26AM EST

Wedbush Initiates Coverage On Black Diamond Therapeutic with Outperform Rating

Wedbush analyst Robert Driscoll initiates coverage on Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform rating.